#OTILT Rifaximin is used for treatment of hepatic encephalopathy in patients w/ cirrhosis. It works by targeting urease-producing bacteria as well as reducing absorption of dietary & bacterial ammonia. https://t.co/5s1IATrklX.
Open Access UCL Research: Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis https://t.co/FWEYAZc9Ej
@mistral_deep そういうことで良いと思います😀コクランレビューでも不顕性・顕性肝性脳症には効果があるけど、予後に対する効果は乏しいとされています🙃https://t.co/NZfoOQ36Yz
RT @CochraneFrance: 💊Rifaximine pour la prévention et le traitement de l'encéphalopathie hépatique chez les personnes atteintes de cirrhose…
💊Rifaximine pour la prévention et le traitement de l'encéphalopathie hépatique chez les personnes atteintes de cirrhose 🔎Revue @cochranecollab évaluant 41 essais portant sur 4545 personnes 🔗https://t.co/vI5gDuVFd7 @CochraneCan_FR @CochraneBelgium @Cochran
RT @harryzac: After years in the writing, I'm thrilled to have this finally published #hepatology #rifaximin #hepaticencephalopathy @fadyka…
New NNT→Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis https://t.co/sci37eymCa
RT @CochraneLibrary: 💊 #Rifaximin for prevention & treatment of hepatic encephalopathy in people with #cirrhosis 📚 🔍 Evidence from 41 clin…
RT @CochraneLibrary: 💊 #Rifaximin for prevention & treatment of hepatic encephalopathy in people with #cirrhosis 📚 🔍 Evidence from 41 clin…
💊 #Rifaximin for prevention & treatment of hepatic encephalopathy in people with #cirrhosis 📚 🔍 Evidence from 41 clinical studies involving 4545 people was looked at for this #SystematicReview https://t.co/JoMfLSwZpY
After years in the writing, I'm thrilled to have this finally published #hepatology #rifaximin #hepaticencephalopathy @fadykamel1997 @liselottegluud @jaclyntan @CochraneUK @ISHENliver https://t.co/ZEgMOng1IG https://t.co/LOqmED6pGO